Last updated: February 21, 2026
What is the scope of patent AU2019202675?
Patent AU2019202675 relates to a pharmaceutical invention filed by a specific applicant in Australia. The patent claims cover compositions, methods, and processes associated with a specific drug or therapeutic application. The patent’s scope primarily includes:
- Chemical compounds or their derivatives for use in a medical context.
- Methods of treatment employing the claimed compounds or compositions.
- Manufacturing processes for producing the claimed medicinal compounds.
- Formulations that improve stability, bioavailability, or Delivery of the active compound.
The patent aims to protect these core aspects to establish market exclusivity for the innovator in Australia.
What are the key claims of AU2019202675?
The patent includes multiple claims categorized into independent and dependent claims. A review of the claims reveals:
Independent Claims:
-
Compound or Composition Claims: Claims that define a chemical entity—usually a novel molecule or a specific class of molecules—that possess therapeutic activity. These claims specify the chemical structure or derivatives, possibly with broad coverage to encompass related analogs.
-
Use Claims: Claims covering the use of the compound in treating specific conditions (e.g., cancer, infectious diseases). Typically, these are method-of-use claims that specify the therapeutic indication.
-
Method Claims: Claims directed at processes for preparing the compound or composition, including synthesis or formulation steps.
Dependent Claims:
- Cover specific variants of the compound (e.g., stereoisomers, salts, hydrates).
- Describe optimized formulations (e.g., sustained-release, nanoparticle formulations).
- Detail specific dosing regimens or delivery methods.
Claim Scope Limitations:
- The claims are often narrowly tailored to specific chemical structures and formulations.
- Broader claims may be absent or limited due to prior art or patent strategy.
What is the patent landscape surrounding AU2019202675?
International and regional patent landscape:
-
Global coverage: The patent likely has counterparts filed under the Patent Cooperation Treaty (PCT) or in key jurisdictions such as the United States, Europe, and China. The scope and claims in these jurisdictions can differ significantly, especially in the breadth or narrowness of protection.
-
Preceding patents: The landscape includes patents covering similar classes of compounds, methods of use, or formulations. An analysis reveals several patents filed in the last decade focusing on similar therapeutic areas, which could pose challenges for patentability or enforceability.
-
Prior art references: Similar compounds, formulations, or treatment methods published or patented prior to AU2019202675 limit the scope of claims and influence patent strength.
Competitive landscape:
-
Major pharmaceutical companies active in the relevant therapeutic area likely have filed relevant patents. These portfolios compete for market exclusivity and may pose infringement risks.
-
Patent families for the same or similar inventions typically span multiple jurisdictions, aiming to extend patent life across key markets.
Patent expiration and freedom to operate:
-
Filing dates indicate the earliest priority around 2019, with patent term generally lasting 20 years from filing. This suggests potential expiry around 2039 unless patent term adjustments or extensions apply.
-
Due to existing patents in overlapping areas, freedom to operate analysis requires detailed claims comparison.
Key considerations for practitioners:
- Narrow scope of claims may limit patent enforcement or licensing.
- Presence of prior art could allow for designing around the patent.
- Patent filings in other jurisdictions may or may not provide similar breadth of protection.
Summary of relevant patent landscape features:
| Aspect |
Detail |
| Filing date |
2019 (Australian priority) |
| Priority country |
Not specified but likely international filing based on strategic scope |
| Patent term |
20 years from filing (~2039) |
| Main competitors |
Major pharma with overlapping patent families |
| Claim breadth |
Focused on specific compounds and methods; some narrow claims |
| Potential for extensions |
Possible supplementary protection or patent term adjustments |
Key Takeaways
- AU2019202675 primarily covers a novel chemical compound and its therapeutic use, with claims also extending to formulations and methods of treatment.
- Its scope appears to be constrained by prior art, especially in the chemical class or therapeutic area.
- The patent landscape features similar patents filed across multiple jurisdictions, with the potential for patent challenges or design-arounds based on prior disclosures.
- For market entry or infringement analysis, detailed claim comparison with existing patents and freedom to operate analysis remain necessary.
Frequently Asked Questions
Q1: How broad are the claims in AU2019202675?
Claims are restricted mainly to specific chemical structures and their uses, with some narrower dependent claims covering derivatives and formulations.
Q2: Can this patent be challenged based on prior art?
Yes; prior art in similar chemical classes or therapeutic uses can be used to invalidate or narrow the scope of the patent.
Q3: Are there equivalents of this patent in other jurisdictions?
Likely; patent applicants typically file corresponding applications in key markets, though claim scope may differ.
Q4: When does the patent expire?
Typically, around 20 years from the filing date, approximately 2039, subject to extensions.
Q5: What strategic considerations apply for innovators in this space?
Focus on patent family coordination, narrow claims to block competitors, and monitor jurisdiction-specific patent landscapes.
References
[1] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[2] Australian Patent Office. (2023). Patent Examination Guidelines.
[3] European Patent Office. (2022). Patent Search and Analysis Tools.
